IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: Europe/Mideast

Bayer confirms outlook, acquires nutrition firm

12:19 PM MST | November 12, 2012 | —Natasha Alperowicz

Bayer reported a 17.8% fall in third-quarter net income, to €528 million ($682.2 million) on sales 11.5% higher, at €9.67 billion. Ebitda before special items improved 2.2%, to €1.85 billion. Net income was down because of special charges, particularly for legal claims and restructuring. The company, meanwhile, confirmed earlier forecasts for the whole of 2012. Dekkers: Quarterly sales good all around. Condon: Safeguarding harvests is a major issue. “The upward trend in our life-science businesses, Bayer HealthCare and Bayer CropScience...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa